Sales at 54 Billion Won, Operating Profit at 9.2 Billion Won, Net Profit at 7.8 Billion Won on a Separate Basis
All Treasury Shares Cancelled...
Pursuing Process Optimization with AI and Robots

Yuyu Pharma announced that, based on its separate financial statements, sales in the second quarter of this year reached 54 billion won, with operating profit at 9.2 billion won and net profit at 7.8 billion won.

Exterior view of the headquarters of Yuyu Pharmaceutical. Yuyu Pharmaceutical

Exterior view of the headquarters of Yuyu Pharmaceutical. Yuyu Pharmaceutical

View original image

According to a disclosure on August 13, Yuyu Pharma's sales increased by 19.7% compared to the same period last year, while operating profit and net profit rose by 109.3% and 252.9%, respectively.

In June, Yuyu Pharma cancelled all treasury shares it held, including common and preferred shares. The company is pursuing process optimization by utilizing AI-based work tools in its production processes, and plans to complete the introduction of robots and the establishment of a solar eco-friendly energy system in the second half of the year.



Noyong Park, CEO of Yuyu Pharma, said, "We will not be content with achieving a surplus in the second quarter following the first quarter, but will continue to manage key management indicators through cost reduction by converting to a smart factory, aiming for another profitable year."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing